Cambridge BioScience Corp receive Federal Drug Administration approval "Investigational New Drug" filing begin human clinical trial generation diagnostic test AIDS. The company anticipates test release worldwide market late 1987 1988. Cambridge BioScience expect file soon "Investigational New Drug" FDA screen test detect AIDS antibodies. This test evaluate emergency situation African nation require highly train technician nor instrumentation accord company. Cambridge BioScience explain filing human clinical trial AIDS receive FDA approval utilizes recombinant-DNA technology detect screen antibody blood serum patient infect AIDS-causing virus. The separate plan filing FDA revolutionary five-minute latex agglutination screen test detect AIDS antibody company said. This test utilizes latex bead coat CBC's recombinant antigen attract hold AIDS antibody form cluster (agglutination) indicates positive result. Reuter 